← FDA Drug Approvals (Drugs@FDA)

SUMATRIPTAN; NAPROXEN SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PAR PHARM · Approved 2013-11-29

Drug application

FDA Application #

ANDA090753

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUMATRIPTAN; NAPROXEN SODIUM

Generic name

Sumatriptan

Active ingredients

SUMATRIPTAN; NAPROXEN SODIUM

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

PAR PHARM

First approval

2013-11-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown